Multidrug-Resistant Tuberculosis Treatment in North Korea: Is Scale-Up Possible?
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 27483430.
- Also identified by DOI 10.1371/journal.pmed.1002062 and PMC identifier 4970717.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Kwonjune Seung and colleagues describe the Eugene Bell Foundation's experience of treating MDR-TB in North Korea.
Medical subject headings
- Antitubercular Agents
- Capacity Building
- Tuberculosis, Multidrug-Resistant